PCN245 Examining Longitudinal Practice Patterns in the use of ANTI-PD-1 and ANTI-PD-L1 Inhibitors as First-Line Therapy in Non-Small Cell Lung Cancer Patients in the US

2021 ◽  
Vol 24 ◽  
pp. S65-S66
Author(s):  
R. Veluswamy ◽  
G. Barnes ◽  
R. Strauss ◽  
D. Harrough ◽  
B. Tang
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Practice Patterns ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
First Line Therapy ◽  
Line Therapy ◽  
The Us

Outcome of Surgical Resection as a First Line Therapy in T3 Non-small Cell Lung Cancer Patients

2013 ◽  
Vol 37 (11) ◽  
pp. 2574-2580 ◽  
Author(s):  
Tomoyoshi Takenaka ◽  
Masakazu Katsura ◽  
Yasunori Shikada ◽  
Sadanori Takeo
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Surgical Resection ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
First Line Therapy ◽  
Line Therapy

Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients

2016 ◽  
Vol 5 (S7) ◽  
pp. S1443-S1448
Author(s):  
Luis E. Raez ◽  
Christian Rolfo ◽  
Mauricio Mahave ◽  
Christian Caglevic
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals PS01.75: Safety Outcomes in Advanced Non–Small Cell Lung Cancer Patients Treated with First-Line Platinum-Based Regimens in the US

2016 ◽  
Vol 11 (11) ◽  
pp. S318
Author(s):  
Jong Seok Kim ◽  
Lei Chen ◽  
Belen San Antonio ◽  
Yajun Emily Zhu ◽  
Lucy Mitchell ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
The Us ◽  
Safety Outcomes
Sign in / Sign up

Export Citation Format

Share Document